Weekly Digest – 11-17 Jul 2023 Weekly Digest – 11-17 Jul 2023 17 Jul 2023: XPOVIO (selinexor) / Relapsed and/or Refractory Multiple Myeloma / Antengene: Received regulatory approval in Hong Kong HKSAR has approved an NDA for Selinexor + Dexamethasone […]
Weekly Digest – 11-17 Jul 2023 Weekly Digest – 11-17 Jul 2023 12 Jul 2023: BRUKINSA (zanubrutinib) / Obinutuzumab / R/R Follicular Lymphoma / BeiGene: The US FDA accepted the sNDA for review BeiGene seeks FDA approval for BRUKINSA in […]
Weekly Digest – 11-17 Jul 2023 Weekly Digest – 11-17 Jul 2023 12 Jul 2023: BBP-398 / Osimertinib / EGFR mutated NSCLC / LianBio / AstraZeneca: Announced a clinical supply agreement LianBio announced a clinical supply agreement with AstraZeneca in […]
Weekly Digest – 11-17 Jul 2023 Weekly Digest – 11-17 Jul 2023 12 Jul 2023: ENHERTU (trastuzumab deruxtecan) / HER2-low metastatic breast cancer / Daiichi Sankyo / AstraZeneca: Received China NMPA approval This approval was based on the results from […]
Weekly Digest – 11-17 Jul 2023 Weekly Digest – 11-17 Jul 2023 11 Jul 2023: COLUMVI (glofitamab-gxbm) / R/R DLBCL / Roche: Approved in the EU Based on the results from the Phase 1/2 NP30179 study, glofitamab received conditional approval […]
